Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Organon & Co. Director's Dealing 2021

May 7, 2021

31461_dirs_2021-05-07_05298b3d-d796-4e14-9461-d0b4e8e832c6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Organon & Co. (OGN)
CIK: 0001821825
Period of Report: 2021-05-07

Reporting Person: WALSH MATTHEW M (Chief Financial Officer)